Literature DB >> 2606909

Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement.

Y Sugita1, T Tobe, E Oda, M Tomita, K Yasukawa, N Yamaji, T Takemoto, K Furuichi, M Takayama, S Yano.   

Abstract

Human erythrocytes contain a membrane protein, MACIF, which inhibits the formation of a membrane attack complex (MAC) of complement. We have cloned and sequenced the complementary DNA of MACIF messenger RNA. The amino acid sequence predicted from its nucleotide sequence consists of 128 amino acids. The amino-terminal 25 residues may correspond to a signal peptide. The carboxy-terminal sequence confirmed that MACIF is a glycosylphosphatidylinositol (GPI)-anchored protein. The amino acid sequence of MACIF was partially determined by established techniques for protein chemistry and the resultant sequence was consistent with that predicted from the nucleotide sequence. The results of sequence analyses also suggested that asparagine at the 18th position was N-glycosylated. When mRNA obtained from the MACIF cDNA clone with SP6 RNA polymerase was microinjected into Xenopus oocytes, the oocytes synthesized a product which exhibited MACIF activity and reacted with anti-MACIF antibody. Comparison of the predicted sequence revealed significant homology with mouse Ly-6 antigens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606909     DOI: 10.1093/oxfordjournals.jbchem.a122893

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  21 in total

1.  Host cell invasion by Toxoplasma gondii is temporally regulated by the host microtubule cytoskeleton.

Authors:  Kristin R Sweeney; Naomi S Morrissette; Stephanie LaChapelle; Ira J Blader
Journal:  Eukaryot Cell       Date:  2010-04-30

2.  Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activity.

Authors:  Lin Wu; Sanbao Su; Fengming Liu; Tao Xu; Xiaoxiao Wang; Yan Huang; Xinlu Sun; Xiaowen Ge; Ting Chen; Huixia Liu; Chun Wang; Michael Chorev; Ting Xu; Xuebin Qin
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.

Authors:  D M Lublin; E S Thompson; A M Green; C Levene; M J Telen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 4.  Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.

Authors:  C J Parker
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 5.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 6.  The good and evil of complement activation in HIV-1 infection.

Authors:  Qigui Yu; Richard Yu; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

Review 7.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

Review 8.  Complement in human reproduction: activation and control.

Authors:  I A Rooney; T J Oglesby; J P Atkinson
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 9.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

10.  Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein.

Authors:  J G Petranka; D E Fleenor; K Sykes; R E Kaufman; W F Rosse
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.